DNDN
DNDN Articles
You know that if one sector has continued to consolidate through time, it is the biotech sector. We often hear rumors about “the next biotech buyout.” Today’s rumor mill around biotech is...
Published:
Last Updated:
The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short sellers generally have retreated from their gambles on biotech firms. For the period...
Published:
The short interest data is out from the July 31 settlement date and we have compared these levels to the prior July 13 settlement date. It seems that there were some big changes with some key cult...
Published:
Last Updated:
The three major US stock indexes opened mixed this morning following the unemployment report from the Eurozone, which showed that the 11.2% rate had remained unchanged. The Eurozone consumer price...
Published:
Last Updated:
Canaccord Genuity provided 24/7 Wall St. with a research note on its downgrade of Dendreon (NASDAQ: DNDN): DNDN Target Cut Following Dendreon’s (DNDN) Q2 2012 results Canaccord Genuity...
Published:
Photo by Spencer Platt/Getty ImagesThe broader stock market is mixed Tuesday, with the Dow Jones Industrial Average down 0.07%, the Nasdaq up 0.28% and the S&P 500 up 0.01%. Today’s big winners...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday morning. Broadsoft Inc. (NASDAQ: BSFT) raised to Buy at Goldman Sachs....
Published:
Last Updated:
Yahoo! Inc.’s (NASDAQ: YHOO) former interim CEO, Ross Levinsohn, quits. (Reuters) Manchester United sets IPO terms. (Reuters) The jury is selected in the Apple Inc. (NASDAQ: AAPL) vs. Samsung...
Published:
Dendreon (NASDAQ: DNDN), the small biotech firm with a cult following a among Wall St. traders, posted earnings today and slashed its staff. The stock dropped immediately after the news, and was...
Published:
The short interest data is out from the July 13 settlement date and we have compared these levels to the prior June 29 settlement date. It seems that there were some big changes with some key cult...
Published:
Last Updated:
What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the M&A block. Monday’s...
Published:
Last Updated:
The short interest data is out from the June 29 settlement date. It seems that there were some big changes with some key cult stocks and actively traded stocks seeing big changes over the June 15...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Wednesday. Alcoa Inc. (NYSE: AA) Cut to Underperform at BMO Capital Markets....
Published:
Last Updated:
More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in the biotech and emerging...
Published:
Last Updated:
The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it is...
Published:
Last Updated: